Alector (ALEC) Revenue (2018 - 2026)

Alector's (ALEC) quarterly Revenue came in at $1.0 million in Q1 2026, down 71.53% year-on-year from $3.7 million in Q1 2025, and down 83.23% on a QoQ basis from $6.2 million in Q4 2025.

Alector (ALEC) Revenue (2018 - 2026) Analysis & Trends

Alector (ALEC) has 9 years of Revenue data on file, last reported at $1.0 million in Q1 2026.

  • On a quarterly basis, Revenue fell 71.53% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $18.4 million, a 79.15% decrease from a year earlier, with the FY2025 full-year figure at $21.0 million, down 79.07% from the prior year.
  • Revenue for Q1 2026 stood at $1.0 million, down from $6.2 million in the prior quarter.
  • Over the last five years, Revenue for ALEC reached as high as $79.9 million in Q2 2022 and fell as low as $1.0 million in Q1 2026.
  • Historically, Revenue has averaged $20.8 million across 5 years, with a median of $15.1 million in 2024.
  • On a YoY basis, Revenue climbed as much as 1115.76% in 2022 and fell as far as 91.86% in 2022.
  • Year by year, Revenue stood at $14.4 million in 2022, then increased by 5.19% to $15.2 million in 2023, then soared by 257.08% to $54.2 million in 2024, then plunged by 88.5% to $6.2 million in 2025, then tumbled by 83.23% to $1.0 million in 2026.
  • Per Business Quant data, the three most recent Revenue figures were $1.0 million in Q1 2026, $6.2 million in Q4 2025, and $3.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.51 Bn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.56 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Alector 164.78 Mn -41.74 Mn - 1.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.05 Mn
Dec 31, 2025 6.24 Mn
Sep 30, 2025 3.26 Mn
Jun 30, 2025 7.87 Mn
Mar 31, 2025 3.67 Mn
Dec 31, 2024 54.24 Mn
Sep 30, 2024 15.34 Mn
Jun 30, 2024 15.08 Mn
Mar 31, 2024 15.89 Mn
Dec 31, 2023 15.19 Mn
Sep 30, 2023 9.11 Mn
Jun 30, 2023 56.21 Mn
Mar 31, 2023 16.55 Mn
Dec 31, 2022 14.44 Mn
Sep 30, 2022 14.85 Mn
Jun 30, 2022 79.85 Mn
Mar 31, 2022 24.47 Mn
Dec 31, 2021 13.99 Mn
Sep 30, 2021 182.41 Mn
Jun 30, 2021 6.57 Mn